ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,527.20
      1.07%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,918.17
      3.24%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Onconova Therapeutics Inc (ONTX)

      7. Onconova Therapeutics Inc (ONTX) Financials

      Onconova Therapeutics Inc

      Onconova Therapeutics Inc (ONTX)

      NASDAQ
      0.9953
      0.00
      (0.00%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      0.9953
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Onconova Therapeutics Inc Financial Summary

      The current ONTX market cap is 20.9M. The company's latest EPS is USD -0.9021 and P/E is -1.11.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 56k57k57k56k56k
      Operating Income -6.14M-4.61M-5.09M-4.46M-5.21M
      Net Income -5.78M-4.25M-4.74M-4.18M-4.98M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.18M231k226k226k226k
      Operating Income -21.7M-24.99M-16.5M-19.63M-20.3M
      Net Income -21.5M-25.16M-16.16M-18.96M-18.95M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 35.06M30.47M27.04M22.68M18.17M
      Total Liabilities 12.19M11.57M12.52M12.01M12.16M
      Total Equity 22.88M18.9M14.52M10.67M6.02M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 23.67M19.99M55.48M39.37M22.68M
      Total Liabilities 12.1M13.81M9.36M11.06M12.01M
      Total Equity 11.57M6.18M46.12M28.31M10.67M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.54M-9.03M-13.5M-17.93M-4.42M
      Investing N/A N/A -14k-14k N/A
      Financing N/A N/A N/A N/A N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -20.83M-23.08M-19.49M-16.29M-17.93M
      Investing -55k-15k N/A N/A -14k
      Financing 26.65M19.36M55.56M N/A N/A

      Stats and Ratios

      Market Cap 20.9M
      Price to Earnings Ratio -1.11
      Price to Sales Ratio 92.59
      Price to Cash Ratio 1.01
      Price to Book Ratio 1.97
      Dividend Yield -

      Share Statistics

      Shares Outstanding 21M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -0.47%
      52 Week High 1.10
      52 Week Low 0.5509
      Spread (Intraday) 0.05 (4.76%)

      Company Info

      Company Name Onconova Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.onconova.com
      Industry pharmaceutical preparations (2834)